found that homoharringtonine had a preferential antileukemia effect against FLT3-mutated AML cells in vitro, which was mediated by an inhibition of protein synthesis and a reduction in short-lived proteins including the total and phosphorylated forms of FLT3 and its resultant downstream signaling proteins (43). Here, FLT3 is linked to acute myeloid leukemia.